Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 1439

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 6
Chunk 1439
---
 Basic and Diluted 
     454,582  
     66,314 

See accompanying notes to these consolidated
financial statements which are an integral part of these consolidated financial statements.

F-4

60 DEGREES PHARMACEUTICALS,
INC.

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’
EQUITY 

    For
    the Year Ended December 31, 2024 

    Series
    A 
    Preferred Stock  
    Common
    
    Stock(1)  
    Additional
    Paid-In  
    Accumulated  
    Accumulated
    Other Comprehensive  
    Total
    
    Shareholders’
    Equity
    Attributable  
    Noncontrolling
                                                                                Interest
                                            on  
    Total
    Shareholders’ 

    Shares  
    Amount  
    Shares  
    Amount  
    Capital(1)  
    Deficit  
    Income
    (Loss)  
    to
    60P  
    Shareholders  
    Equity 
  
    Balance—December
    31, 2023 
     78,803  
    $9,858,040  
     96,847  
    $10  
    $27,457,373  
    $(32,580,850) 
    $135,561  
    $4,870,134  
    $(72,038) 
    $4,798,096 
  
    Issuance
    of common stock and warrants, net of underwriting discounts and offering costs paid at closing and deferred offering costs (Note 6) 
     -  
     -  
     87,683  
     9  
     1,898,287  
     -  
     -  
     1,898,296  
     -  
     1,898,296 
  
    Issuance
    of common stock upon exercise of Pre-Funded Warrants 
     -  
     -  
     211,163  
     21  
     10,942  
     -  
     -  
     10,963  
     -  
     10,963 
  
    Issuance
    of shares for RSUs 
     -  
     -